Advertisement
Advertisement
Trending on Urology Times
1
Durvalumab plus BCG improves DFS in papillary-only, BCG-naïve NMIBC
2
Updated CAPItello-281 data show numerical OS benefit with capivasertib in PTEN-deficient mHSPC
3
Alberto Briganti, MD, PhD, on the PROTEUS substudy in high-risk prostate cancer
4
Adding darolutamide to ADT and radiation improves MFS in very high-risk localized prostate cancer
5